SV

Suresh Voondinty

Active Director Director DIN 10299564
DIN 10299564 First appointment Aug 2023 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Suresh Voondinty

Data last updated:

Suresh Voondinty is a Director at Peoples Lepra Foundation (since 2023). The company operates in Healthcare. Peoples Lepra Foundation reported revenue of ₹2.56 Cr (FY 2024).

DIN 10299564
Primary Designation Director
Industry Healthcare
First Appointment 30 Aug 2023
Oldest Company Age 6 yrs
Largest company Peoples Lepra Foundation · ₹2.56 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Peoples Lepra Foundation U85190TG2020NPL141901
Director30 Aug 20232020₹2.56 Cr (FY 2024)Active

Board colleagues of Suresh Voondinty

NameDINCompanyDesignation
Guduri Swamy Reddy10691990Peoples Lepra FoundationDirector

Directorship timeline

Open interactive timeline →
Peoples Lepra Foundation
Premium access

Shareholding and investment profile for Suresh Voondinty

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Voondinty

Suresh Voondinty currently holds 1 directorship: Peoples Lepra Foundation (Director, since 30 Aug 2023, revenue ₹2.56 Cr (FY 2024)).

Suresh Voondinty was first appointed on 30 Aug 2023 as Director at Peoples Lepra Foundation.

The current boards of Suresh Voondinty's companies include Guduri Swamy Reddy (Peoples Lepra Foundation).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available